Cathay General Hospital

The trials here

What the 16 trials at this site are about, from their registry records.

Conditions

• Chronic kidney disease3 trials
• Obesity3 trials
• Atrial fibrillation2 trials
• Coronary artery disease2 trials
• Diabetic foot ulcer2 trials
• Fatty liver disease (MASLD/MASH)2 trials
• Obstructive sleep apnoea2 trials
• Heart failure1 trial
• Ovarian cancer1 trial
• Sjögren's disease1 trial
• Stroke1 trial

Phase

• Phase 310 trials
• Phase 42 trials
• Phase 21 trial

Status

• Recruiting7 trials
• Active, not recruiting3 trials
• Completed3 trials
• Not yet recruiting2 trials
• Enrolling by invitation1 trial

Lead sponsor

• Eli Lilly and Company3 trials
• Novo Nordisk A/S3 trials
• Cathay General Hospital2 trials
• Janssen Research & Development, LLC2 trials
• Abbott Medical Devices1 trial
• and 5 more

Running trials

• Not yet recruiting

  Home Monitor for AA Burden Detection IIT in TWN

  NCT07572279· National Taiwan University Hospital· Source

  Contact: SHIH-YU HUANG

• Recruiting

  A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

  NCT07794579· Phase 3· Eli Lilly and Company· Source

  Contact: Hai-Hua Chuang (principal investigator)

• Recruiting

  AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

  NCT07571005· Phase 3· Novo Nordisk A/S· Source

  Contact: Novo Nordisk

• Recruiting

  AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

  NCT07571109· Phase 3· Novo Nordisk A/S· Source

  Contact: Novo Nordisk

• Enrolling by invitation

  Investigation on the Impact of Finerenone on Myocardial Remodeling in Patients With Diabetic Kidney Disease and Heart Failure

  NCT07442448· Phase 4· Cathay General Hospital· Source

• Recruiting

  A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)

  NCT07241390· Phase 3· Eli Lilly and Company· Source

  Contact: Chi-Hung Huang (principal investigator)

• Recruiting

  A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

  NCT07165028· Phase 3· Eli Lilly and Company· Source

  Contact: Hai-Hua Chuang (principal investigator)

• Active, not recruiting

  EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)

  NCT06531824· Phase 3· Boehringer Ingelheim· Source

• Recruiting

  The Registry of Genetic Alterations of Taiwan Ovarian Cancer

  NCT06127446· National Health Research Institutes, Taiwan· Source

  Contact: Ya-Ling Wu

• Recruiting

  A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer

  NCT05930210· Phase 3· Energenesis Biomedical Co., Ltd.· Source

  Contact: Chi-Ming Pu, Dr.

• Active, not recruiting

  A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation

  NCT05757869· Phase 3· Janssen Research & Development, LLC· Source

• Active, not recruiting

  Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)

  NCT04822181· Phase 3· Novo Nordisk A/S· Source

• Recruiting

  Abbott Vascular Medical Device Registry

  NCT04573660· Abbott Medical Devices· Source

  Contact: Chi-Hung Huang (principal investigator)

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Obesity3 recruiting
• Chronic kidney disease2 recruiting
• Obstructive sleep apnoea2 recruiting
• Atrial fibrillation1 recruiting
• Coronary artery disease1 recruiting
• Diabetic foot ulcer1 recruiting
• Fatty liver disease (MASLD/MASH)1 recruiting
• Heart failure1 recruiting
• Ovarian cancer1 recruiting
• Stroke1 recruiting

Closed trials

• Completed

  Efficacy and Safety of SHJ002 Ophthalmic Solution in the Treatment of Corneal Erosion in Sjogren's Patients

  NCT06381986· Phase 2· Sunhawk Vision Biotech, Inc.· Source

• Completed

  A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

  NCT05754957· Phase 3· Janssen Research & Development, LLC· Source

• Completed

  Fespixon Cream for the Treatment of Chronic Diabetic Foot Ulcers (TEXAS 1A, 2A) in Dialysis Patients

  NCT05338463· Phase 4· Cathay General Hospital· Source